According to BIO President and CEO Jim Greenwood, BIO supports the efforts of the House Judiciary Committee to curb abuse of the patent system. However, BIO is concerned that H.R. 9, the Innovation Act of 2015, goes beyond targeting abusive practices, including with respect to its excessive pleading requirements, mandatory stays of discovery, and mechanisms for joinder of third-party investors, licensors, and collaborators in all patent-related cases.